Based on the verification of the FOXJ2/SLAMF8/TREM1 pathway, we explored whether TREM1 deletion ameliorated SLAMF8‐ or FOXJ2‐mediated APS pathogenesis in vitro. The gene discussed is TREM1; the disease is autoimmune polyendocrinopathy.